SMS Pharma: Sustainability and FY25 Turnover Confirmed

SMS Pharmaceuticals Limited reported a turnover of INR 7,82,74,81,188 and a net worth of INR 6,73,06,97,288 for the financial year 2024-25. The company's core business of manufacturing Active Pharmaceutical Ingredients (APIs), intermediates, custom pharmaceutical services, and nutraceuticals accounted for 99.21% of its turnover. Exports contributed 69% of the total turnover.

In FY 2024-25, SMS Pharmaceuticals recorded 1,173 permanent employees and 693 permanent workers. The employee turnover rate was 15.26% (male 5.68%, female 9.58%), while the worker turnover rate was 8.99% (male 8.99%, female 0%). The company faced a penalty of INR 352,000 from BSE Limited and National Stock Exchange of India Limited for non-compliance with SEBI LODR regarding the composition of the Nomination and Remuneration Committee.

SMS Pharmaceuticals is actively engaged in sustainability initiatives, including the elimination of 1,4-Dioxane, Ethyl Acetate, and n-Heptane from its solvent approach. The company's total energy consumption from non-renewable sources was 562940.47 GJ/M.Tonne, with a waste intensity of 0.90 MT/MT. Water withdrawal totaled 296,576.95 kiloliters. The company also reported Scope 1 and Scope 2 greenhouse gas emissions of 37300.11 and 52416.47 metric tonnes of CO2 equivalent, respectively.